Marcin Koba

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Mass Spectrometry

Structure Activity Relationship

Myasthenia Gravis

Top Venues

Molecules (Basel, Switzerland)

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Piotr Kośliński, Łukasz Rzepiński, Marcin Koba, Zdzisław Maciejek, Mariusz Kowalewski, Emilia Daghir-Wojtkowiak
Comparative Analysis of Serum Amino Acid Profiles in Patients with Myasthenia Gravis and Multiple Sclerosis. Journal of clinical medicine 13 (14) (2024)
Piotr Kośliński, Łukasz Rzepiński, Marcin Koba, Zdzisław Maciejek, Mariusz Kowalewski, Emilia Daghir-Wojtkowiak
Comparative Analysis of Serum Amino Acid Profiles in Patients with Myasthenia Gravis and Multiple Sclerosis. Journal of clinical medicine 13 (14) (2024)
Piotr Kośliński, Łukasz Rzepiński, Marcin Koba, Zdzisław Maciejek, Mariusz Kowalewski, Emilia Daghir-Wojtkowiak
Comparative Analysis of Serum Amino Acid Profiles in Patients with Myasthenia Gravis and Multiple Sclerosis. Journal of clinical medicine 13 (14) (2024)
Piotr Kośliński, Robert Pluskota, Marcin Koba, Zygmunt Siedlecki, Maciej Śniegocki
Comparative Analysis of Amino Acid Profiles in Patients with Glioblastoma and Meningioma Using Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS). Molecules (Basel, Switzerland) 28 (23) (2023)
Marcin Gackowski, Burhanuddin Madriwala, Renata Studzińska, Marcin Koba
Novel Isosteviol-Based FXa Inhibitors: Molecular Modeling, In Silico Design and Docking Simulation. Molecules (Basel, Switzerland) 28 (13) (2023)
Marcin Gackowski, Karolina Szewczyk-Golec, Katarzyna Mądra-Gackowska, Robert Pluskota, Marcin Koba
Quantitative Structure-Activity Relationship Analysis of Isosteviol-Related Compounds as Activated Coagulation Factor X (FXa) Inhibitors. Nutrients 14 (17) (2022)
Marcin Gackowski, Karolina Szewczyk-Golec, Robert Pluskota, Marcin Koba, Katarzyna Mądra-Gackowska, Alina Woźniak
Application of Multivariate Adaptive Regression Splines (MARSplines) for Predicting Antitumor Activity of Anthrapyrazole Derivatives. International journal of molecular sciences 23 (9) (2022)
Anna Welz, Marcin Koba, Piotr Kośliński, Joanna Siódmiak
Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs. Journal of clinical medicine 11 (7) (2022)
Anna Przybylska, Agnieszka Chrustek, Beata Sperkowska, Marcin Koba, Dorota M Olszewska-Słonina
Safety Assessment of Foods and Drinks Consumed by People on a Gluten-Free Diet. Molecules (Basel, Switzerland) 27 (19) (2022)
Anna Welz, Marcin Koba, Piotr Kośliński, Joanna Siódmiak
Rapid Targeted Method of Detecting Abused Piperazine Designer Drugs. Journal of clinical medicine 10 (24) (2021)
Marcin Gackowski, Anna Przybylska, Stefan Kruszewski, Marcin Koba, Katarzyna Mądra-Gackowska, Artur Bogacz
Recent Applications of Capillary Electrophoresis in the Determination of Active Compounds in Medicinal Plants and Pharmaceutical Formulations. Molecules (Basel, Switzerland) 26 (14) (2021)
Anna Przybylska, Marcin Gackowski, Marcin Koba
Application of Capillary Electrophoresis to the Analysis of Bioactive Compounds in Herbal Raw Materials. Molecules (Basel, Switzerland) 26 (8) (2021)
Edyta Socha, Piotr Kośliński, Marcin Koba, Katarzyna Mądra-Gackowska, Marcin Gackowski, Kornelia Kędziora-Kornatowska, Emilia Daghir-Wojtkowiak
Serum amino acid profiles in patients with mild cognitive impairment and in patients with mild dementia or moderate dementia. Amino acids 53 (1) (2021)
Robert Pluskota, Karol Jaroch, Piotr Kośliński, Blanka Ziomkowska, Agnieszka Lewińska, Stefan Kruszewski, Barbara Bojko, Marcin Koba
Selected Drug-Likeness Properties of 2-Arylidene-indan-1,3-dione Derivatives-Chemical Compounds with Potential Anti-Cancer Activity. Molecules (Basel, Switzerland) 26 (17) (2021)
Edyta Socha, Piotr Kośliński, Marcin Koba, Katarzyna Mądra-Gackowska, Kornelia Kędziora-Kornatowska, Marcin Gackowski, Emilia Daghir-Wojtkowiak
Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia. Brain sciences 10 (12) (2020)